Clinical Trial Update: uPAR PET/CT for Staging Advanced and Localised Oral and Oropharyngeal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating uPAR PET/CT for staging advanced and localized oral and oropharyngeal cancer; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Oral Cancer
• Oropharyngeal Cancer

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Oral Cancer, Oropharyngeal Cancer | Phase 2 | Status: UNKNOWN